The effect of treatment with some phase II substrates on hepatic xenobiotic metabolism and the urinary excretion of metabolites of the D-glucuronic acid pathway in the rat.
D000082:Acetaminophen / Q000494:pharmacology; D000818:Animals; D001711:Biotransformation; D003577:Cytochrome P-450 Enzyme System / Q000032:analysis; D004158:Diphenylacetic Acids / Q000494:pharmacology; D004790:Enzyme Induction; D005965:Glucuronates / Q000378:metabolism / Q000652:urine*; D014453:Glucuronosyltransferase / Q000032:analysis*; D006139:Guaiacol / Q000494:pharmacology; D008658:Inactivation, Metabolic; D008099:Liver / Q000201:enzymology*; D008297:Male; D006899:Mixed Function Oxygenases / Q000032:analysis; D009284:Naphthols / Q000494:pharmacology; D010648:Phenylacetates / Q000494:pharmacology; D010666:Phenylpropionates / Q000494:pharmacology; D011435:Propyl Gallate / Q000494:pharmacology; D051381:Rats
D004158:Diphenylacetic Acids; D005965:Glucuronates; D009284:Naphthols; D010648:Phenylacetates; D010666:Phenylpropionates; D000082:Acetaminophen; D006139:Guaiacol; D011435:Propyl Gallate; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; D014453:Glucuronosyltransferase